ARCHIVES

BRMP Workshops Planned; DCT Board Balk At Size of Intramural Budget

This article is from The Cancer Letter archive.

Vol. 06 No. 47 | November 28, 1980

Download PDF Visit The Full Archive

Related Articles

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989

Komen Foundation Calls For Review Of Action Plan’s Goals

October 24, 1996

FTC Report Disagrees With Key Provision Of Biologics Bill Backed By Companies

June 12, 2009

NCI Rethinks Cancer Center Grants

March 14, 2014

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

June 17, 2005